SSG
DRNA

Summit Securities Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Summit Securities Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,263
Closed -$67K – 599
2014
Q3 		$67K Buy
+5,263
New +$67K 0.02% 331